Published in Hepatitis Weekly, March 21st, 2005
Alfred R. Rudolph, MD, chief operating o0fficer of SciClone, said, "Eduardo played an integral role in advancing the development of our lead product Zadaxin, most notably with respect to our U.S. phase 3 hepatitis C clinical trials."
Until a replacement has been...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.